Correlation of Heavy and Light Chain mRNA Copy Numbers to Antibody Productivity in Mouse Myeloma Production Cell Lines
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Manufacturing cell line development at Centocor involves transfection of antibody genes into host cell lines and isolating primary transfectomas that upon subcloning yield high expressing cell lines for the desired antibody. In an attempt to increase productivity of these cell lines, we set out to identify the rate-limiting step in the process of antibody expression and secretion. For this purpose, 30 antibody expressing cell lines with variable antibody expression levels were analyzed for heavy-chain and light-chain mRNA expression levels. Results suggested that the increase in antibody titer of the subclones (compared to their primary clones) was partly due to an increase in heavy-chain and light-chain mRNA levels; higher expressers were associated with approximately 1.0 x 10(7) and 1.5 x 10(7) copies of heavy-chain and light-chain per 10 nanogram of cDNA, respectively. Generally, the level of light-chain mRNA was higher compared to the level of heavy-chain mRNA in a majority of the cell lines, and the difference in their levels was not due to their differential stability. The data generated from all the cell lines tested in this study suggested that there was a correlation of light-chain and heavy-chain transcript levels to antibody productivity, with the coefficient of correlation being 0.59 for light chain and 0.81 for heavy chain. We conclude that transcription of heavy chain and to a lesser extent light chain could be one of the rate-limiting steps in the antibody expression pathway. Hence, methods that would increase these mRNA levels could be beneficial in the attempt to improve the antibody expression level of production cell lines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Production of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032
Kwaks, T. H. J., Barnett, P., Hemrika, W., Siersma, T., Sewalt, R. G. A. B., Satijn, D. P. E., Brons, J. F., van Blokland, R., Kwakman, P., Kruckeberg, A. L., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt814 · Cited by 126
Cited by
Detailed understanding of enhanced specific antibody productivity in NS0 myeloma cells
Khoo, S. H. G., & Al‐Rubeai, M. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22041 · Cited by 38
“Researchers have reported a positive correlation between heavy chain mRNA levels and overall productivity (Barnes et al., 2006; Dorai et al., 2006).”
BackgroundHarraghy, N., Regamey, A., Girod, P.-A., & Mermod, N. (2011) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2011.04.004 · Cited by 37
Reaching the depth of the Chinese hamster ovary cell transcriptome
Jacob, N. M., Kantardjieff, A., Yusufi, F. N. K., Retzel, E. F., Mulukutla, B. C., Chuah, S. H., Yap, M., & Hu, W. (2010) · Biotechnology and Bioengineering · doi:10.1002/bit.22588 · Cited by 33
Klimtchuk, E. S., Prokaeva, T. B., Spencer, B. H., Gursky, O., & Connors, L. H. (2017) · Amyloid · doi:10.1080/13506129.2017.1336996 · Cited by 10
Metadata
- Authors
- Dorai, H., Csirke, B., Scallon, B., & Ganguly, S.
- Venue
- Hybridoma
- Publisher
- SAGE Publications
- Published
- 2006-02
- Volume
- 25
- Issue
- 1
- Pages
- 1-9
- ISSN
- 0272-457X (ISSN-L)
- 1554-0014
- 1557-8348
- OpenAlex
- W1982273552
- Cited by
- 37
- References
- 2
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Correlation of Heavy and Light Chain mRNA Copy Numbers to Antibody Productivity in Mouse Myeloma Production Cell Lines. https://app.cochat.ai/papers/10.1089/hyb.2006.25.1
- The paper
- Dorai, H., Csirke, B., Scallon, B., & Ganguly, S. (2006). Correlation of Heavy and Light Chain mRNA Copy Numbers to Antibody Productivity in Mouse Myeloma Production Cell Lines. Hybridoma. https://doi.org/10.1089/hyb.2006.25.1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.